SARCOMATOID CARCINOMA OF THE LUNG: A CLINICOPATHOLOGICAL STUDY INCLUDING EGFR AND KRAS MUTATION AND ALK PROTEIN EXPRESSION ANALYSIS

被引：0
|
作者：
Jia, X-L [1 ]
Chen, G. [1 ]
机构：
[1] Tongji Univ, Dept Pathol, Sch Med, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China
来源：
RESPIROLOGY | 2011年 / 16卷
关键词：
Sarcomatoid carcinoma; EGFR mutation; KRAS mutation; ALK protein expression;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [41] Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma
    Yuan, Xiao-Han
    Yang, Jie
    Wang, Xin-Yue
    Zhang, Xiao-Ling
    Qin, Ting-Ting
    Li, Kai
    ONCOLOGY LETTERS, 2018, 16 (02) : 2105 - 2112
  • [42] Strong ALK and PD-L1 positive IHC expression related ALK amplification in an advanced lung sarcomatoid carcinoma: A therapeutic trap?
    Gendarme, Sebastien
    Matton, Lise
    Antoine, Martine
    Kerrou, Khaldoun
    Ruppert, Anne-Marie
    Epaud, Christelle
    Cadranel, Jacques
    Fallet, Vincent
    LUNG CANCER, 2021, 152 : 94 - 97
  • [43] Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement: Analysis of two cases and literature review
    Caliez, Julien
    Monnet, Isabelle
    Pujals, Anais
    Rousseau-Bussac, Gaelle
    Boudjemaa, Amel
    Copie-Bergman, Christiane
    Van Nhieu, Jeanne Tran
    Damotte, Dianne
    Leroy, Karen
    Chouaid, Christos
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [44] EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection
    Chowdhuri, Sinchita Roy
    Xi, Liqiang
    Trinh Hoc-Tran Pham
    Hanson, Jeffrey
    Rodriguez-Canales, Jaime
    Berman, Arlene
    Rajan, Arun
    Giaccone, Giuseppe
    Emmert-Buck, Michael
    Raffeld, Mark
    Filie, Armando C.
    MODERN PATHOLOGY, 2012, 25 (04) : 548 - 555
  • [45] Nkx2-4 Mutation Confers Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Sarcomatoid Carcinoma
    Xia, Lexin
    Shao, Yang W.
    Xia, Yang
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (06) : E125 - E126
  • [46] Patterns of β-catenin expression in gastric carcinoma:: Clinicopathological relevance and mutation analysis
    Nabais, S
    Machado, JC
    Lopes, C
    Seruca, R
    Carneiro, F
    Sobrinho-Simoes, M
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2003, 11 (01) : 1 - 9
  • [47] ANALYSIS OF SENSITIVITY OF LUNG SQUAMOUS CARCINOMA WITH EGFR MUTATION TO EGFR-TKIS AND RESISTANT MECHANISM
    Wang, Zhijie
    Li, Zhenxiang
    Yang, Xiaodan
    Bai, Hua
    Zhuo, Minglei
    Duan, Jianchun
    Wang, Jie
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S798 - S798
  • [48] Inverse Relationship Between the Length of the EGFR CA Repeat Polymorphism in Lung Carcinoma and Protein Expression of EGFR in the Carcinoma
    Suzuki, Masaya
    Kageyama, Shinji
    Shinmura, Kazuya
    Okudela, Koji
    Bunai, Tomoyasu
    Nagura, Kiyoko
    Igarashi, Hisaki
    Kiyose, Shinichiro
    Mori, Hiroki
    Tao, Hong
    Coto, Masanori
    Takamochi, Kazuya
    Mochizuki, Takahiro
    Suzuki, Kazuya
    Ohashi, Riuko
    Ogawa, Hiroshi
    Yamada, Takeshi
    Niwa, Hiroshi
    Tsuneyoshi, Toshihiro
    Sugimura, Haruhiko
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (06) : 457 - 461
  • [49] P53 GENE-EXPRESSION IN SARCOMATOID RENAL-CELL CARCINOMA (RCC) - A CLINICOPATHOLOGICAL ANALYSIS AND IMMUNOHISTOCHEMICAL STUDY
    KATTAR, M
    GRIGNON, D
    SARKAR, F
    SAKR, W
    CRISSMAN, J
    LABORATORY INVESTIGATION, 1995, 72 (01) : A78 - A78
  • [50] Detection of ALK and EGFR gene mutation in non-small cell lung adenocarcinoma with brain metastases and its correlation with clinicopathological features
    Mao, Luning
    Xu, Chenyue
    Xiong, Ji
    Wang, Yin
    Wang, Xin
    Liu, Ying
    BRAIN PATHOLOGY, 2019, 29 : 144 - 144
12345